+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Bevacizumab Biosimilars Global Market Report 2024 - Product Thumbnail Image

Bevacizumab Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
From
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
From
Immuno-Oncology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Immuno-Oncology Clinical Trials Market Report 2023-2033

  • Report
  • September 2023
  • 249 Pages
  • Global
From
From
From
From
Fibromyalgia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Fibromyalgia Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 263 Pages
  • Global
From
From
From
Postmenopausal Osteoporosis Treatment Global Market Report 2024 - Product Thumbnail Image

Postmenopausal Osteoporosis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Osteoporosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Osteoporosis Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 340 Pages
  • Global
From
From
Loading Indicator